SCHEMBL13610449

SCHEMBL13610449

c1csc(CSSSCc2ccc3nonc3c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
TSHR P16473 3/20 0.46
HSD17B10 Q99714 2/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KCNJ1 P48048 3/20 0.38
KCNH2 Q12809 3/20 0.38
TOP2A P11388 2/20 0.37
ALOX12 P18054 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ENPP2 Q13822 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPN11 Q06124 1/20 0.33
CXCR2 P25025 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610429 0.78 ALDH1A1 (0.37) ALDH1A1TSHRHSD17B10SMN1; SMN2L3MBTL1
SCHEMBL13610439 0.77 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL13610351 0.77 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL4262202 0.76 TAAR1 (0.46) ALDH1A1TSHRHSD17B10SMN1; SMN2L3MBTL1
SCHEMBL13610448 0.75 ALDH1A1 (0.44) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL13610457 0.75 CYP2A6 (0.39) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL13610466 0.74 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL13610460 0.73 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL13610307 0.73 MAPK1 (0.48) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL13610339 0.73 HPGD (0.46) ALDH1A1TSHRMAPK1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742635-B1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES INC (US) 2018-03-07 EP disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS ALDH1A1 285/4885TSHR 1867/4885HSD17B10 2102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.